Preferred Name
Utility of Bariatric Surgery in the Remission of Type 2 Diabetes Mellitus
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Course Instructor
Abby Massey, MD
Capstone Semester
Fall 2023
Date of Graduation
12-15-2023
Abstract
Objective: Assess whether bariatric surgery is more effective than lifestyle modification and medication in the long-term reduction of hemoglobin A1c (HbA1c) and fasting plasma glucose among obese adults with type 2 diabetes mellitus. Design: Systematic literature review. Methods: A PubMed search was performed utilizing the terms bariatric surgery, type 2 diabetes and remission. In PubMed the following limits and terms were used: published in the last 10 years, humans, full text, clinical trial, randomized control trial, and English. Results: An analysis of three randomized control trials (RCTs) supports bariatric surgery as a modality to induce the remission of type 2 diabetes mellitus (T2DM) in overweight or obese adults, however the results show a decline in success after the first 12 months after surgery. Conclusion: While shown to be beneficial in the initial 12-month period, the long-term data does not support the utility of bariatric surgery alone in the induction of T2DM.
Document Type
Capstone
Recommended Citation
Bower A, Ercoline C, Singh C. Utility of bariatric surgery in the remission of type 2 diabetes mellitus. James Madison University Physician Assistant Program.
Included in
Endocrine System Diseases Commons, Endocrinology, Diabetes, and Metabolism Commons, Nutritional and Metabolic Diseases Commons, Surgery Commons
